Patent · US Active

Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteins

US11135292B2 · kind B2 · utility

1Cited by
4References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 2019
Grant dateOct 5, 2021
Priority date—
Expiry dateOct 12, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for treating and for preventing filovirus infections are disclosed, as well as compositions therefor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.